NEWS
Product exhibitions, press releases, company updates, etc.
CytoChip Receives FDA Clearance and First CLIA Waiver for a Cartridge-Based Complete Blood Count Test
First CLIA Waiver
A performance study of CytoChip’s CBC device in CLIA Waiver settings has been published in ACJP.
A Published Clinical Stud
To be announced.
26
2025-02
The CLIA-waived CitoCBC expands patient access to quick CBC results in physician offices, pharmacies, and home care, enabling data-driven diagnostics. News Provided By CytoChip Inc. February 25, 2025
17
2024-12
Analytical performance of a point-of-care CBC hematology analyzer, including a 5-part differential
A performance study of CytoChip's cBc device in CLlA Waiver settings has been published in AcJP.
15
2022-08
Completed 3rd investment round of $8.5M.
01
2022-04
Moved into new Product Development Center in Suzhou.
